arrow_back Back to App

Improved Alzheimer's Care and Early Detection: New Medicare Rules

This act aims to improve care for individuals with Alzheimer's disease and dementia, and support their caregivers. It introduces changes to the Medicare program to enable early detection of cognitive impairment and ensure access to appropriate diagnostic services and support.
Key points
Medicare wellness visits will include mandatory cognitive impairment detection, allowing for earlier diagnosis.
Individuals with detected cognitive issues will be referred to specialists, diagnostic tests, support groups, and clinical trials.
The Medicare program will promote healthy brain lifestyle choices and incentivize providers for early Alzheimer's diagnosis and care planning.
A study will be conducted on how to accelerate Alzheimer's disease research, including new funding methods and partnerships.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_3354
Sponsor: Rep. Sánchez, Linda T. [D-CA-38]
Process start date: 2021-05-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

CHANGE Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_3354.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-05-19.

What are the main provisions?

Key points include:

  • Medicare wellness visits will include mandatory cognitive impairment detection, allowing for earlier diagnosis.
  • Individuals with detected cognitive issues will be referred to specialists, diagnostic tests, support groups, and clinical trials.
  • The Medicare program will promote healthy brain lifestyle choices and incentivize providers for early Alzheimer's diagnosis and care planning.
  • A study will be conducted on how to accelerate Alzheimer's disease research, including new funding methods and partnerships.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Sánchez, Linda T. [D-CA-38].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Benefits